Advertisement
Screener

NUTRA PHARMA CORP. (NPHC) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

NUTRA PHARMA CORP. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

NUTRA PHARMA CORP. (NPHC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.01 per share for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2017-11-20

  • NUTRA PHARMA CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2017-03-31 was $0.01, a 90.00% decline year-over-year.
  • NUTRA PHARMA CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2016-03-31 was $0.05.
  • NUTRA PHARMA CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2013-03-31 was $0.01.
  • NUTRA PHARMA CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2016 was $0.02, a 98.20% decline from fiscal 2015.
  • NUTRA PHARMA CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2015 was $1.11, a 7.50% decline from fiscal 2014.
  • NUTRA PHARMA CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2014 was $1.20.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed
2017-09-30$0.01
10-Q · filed 2017-11-20
2017-06-30$0.01
10-Q · filed 2017-08-14
2017-03-31$0.01
10-Q · filed 2017-05-17
2016-12-31$0.02
10-K · filed 2017-04-17
2016-09-30$0.02
10-Q · filed 2016-11-22
2016-06-30$0.02
10-Q · filed 2016-08-22
2016-03-31$0.05
10-Q · filed 2016-06-21
2015-12-31$1.11
10-K · filed 2017-04-17
2015-09-30$1.12
10-Q · filed 2015-11-23
2015-06-30$0.29
10-Q · filed 2015-08-18
2014-12-31$1.20
10-K · filed 2016-04-14
$0.03
10-K · filed 2015-04-13
2014-09-30$0.03
10-Q · filed 2014-11-14
2013-03-31$0.01
10-Q · filed 2013-05-20